Findings can lead to gut replacement therapy in people with intestinal deficiencies
Working with gut stem cells from humans and mice, scientists from the Johns Hopkins Children’s Center and the University of Pittsburgh have successfully grown healthy intestine atop a 3-D scaffold made of a substance used in surgical sutures.
In a further step that takes their work well beyond proof of concept, researchers report their laboratory-created intestine successfully regenerated gut tissue in the colons of dogs with missing gut lining.
The experiments, described ahead of print in the journal Regenerative Medicine, bring researchers closer to creating an implantable intestine as replacement therapy for a range of devastating disorders – including infections, cancer and trauma – that result in loss or death of gut tissue. Chief among them is a condition that affects 12 percent of premature newborns, called necrotizing enterocolitis (NEC), which is marked by the rapid death of intestinal cells and permanent loss of intestinal tissue.
The tube-shaped scaffold, designed several years ago in collaboration with Cornell University researchers and composed of biodegradable material similar to that used in surgical sutures, was a big first step on the quest to develop an implantable replacement intestine. But the new work pushes that effort further because it shows how stem cells, when mixed with immune and connective tissue cells, can grow into normal gut tissue around the scaffold and function inside a living mammal.
Researchers caution that a fully functioning replacement intestine for humans is far off, but they say their results have laid the critical groundwork to do so.
“Our experiments show that the architecture and function of our lab-made intestine strikingly resemble those of the healthy human gut, giving us real hope that our model could be used as the backbone for replacement intestine,” says principal investigator David Hackam, M.D., Ph.D., the Johns Hopkins Children’s Center’s surgeon-in-chief, who initiated and conducted most of the work at the University of Pittsburgh.
In an initial set of experiments reminiscent of a peanut butter-and-jelly sandwich technique, researchers took stem cells from the colons of babies undergoing intestinal surgeries and from mice, then added immune cells called macrophages, the body’s scavengers that seek out and engulf debris along with foreign and diseased cells. To this mix, they added cells called fibroblasts, whose function is to form collagen and other connective substances that bind tissues and organs together. The idea, the scientists say, was to create a mixture that closely mimics the natural composition of the gut.
“Intestinal cells do not grow and develop in a vacuum, so we sought to recreate the richness of the human gut, Hackam says. “We took the PB & J approach, adding a layer of stem cells on top of the scaffold, then topping them with a mixture of immune and collagen cells.”
Adding these components, they report, enhanced the growth of intestinal stem cells and differentiation into various mature cell types critical to the function of a healthy intestine. In comparison, stem cells grown in isolation without immune and connective cells in the mix grew more slowly and failed to differentiate well into multiple cell types.
In another set of experiments, researchers added probiotic bacteria to the newly created intestinal tissue. Doing so further amplified the growth and differentiation of new gut cells, specifically the growth of Paneth cells responsible for production of infection-fighting proteins that guard against intestinal infections, Hackam says, a finding that highlights the therapeutic potential of certain probiotics for NEC. Next, the team added bacteria-laden stool cells obtained from infants with NEC, but they observed a dramatic decrease in the number of intestinal cells called goblet cells, which are responsible for the production of protective mucus that coats and shields the intestine – a common occurrence in NEC. The observation, Hackam says, supports the notion that certain gut bacteria present in the colons of babies with NEC are responsible for sparking the rapid death of gut tissue that occurs in the condition.
Next, researchers implanted the newly created intestine into the bellies of mice. In a matter of days, the implanted intestine began producing new intestinal stem cells and stimulated the growth of new blood vessels around the implant. That observation, researchers say, affirmed the ability of the 3-D intestine to spur the growth of new tissue not only in lab dishes, but also in living organisms.
In a final step, the investigators implanted pieces of the newly created intestine – about 1.6 inches in length – into the lower portion of dog colons lacking parts of their intestinal lining. For two months, the dogs underwent periodic colonoscopies and intestinal biopsies. Strikingly, the guts of dogs with implanted intestines healed completely within eight weeks. By contrast, dogs that didn’t get intestinal implants experienced continued inflammation and scarring of their guts.
The Latest on: Regenerative medicine
[google_news title=”” keyword=”Regenerative medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Regenerative medicine
- Regenerative Medicine and the Developing Worldon March 1, 2024 at 4:00 pm
 As the field of regenerative medicine regroups, it is important that recent events do not overshadow the potential benefits of the field. These benefits include the opportunity to improve ...
- Confronting The Silent Threat Of Eye Canceron March 1, 2024 at 5:55 am
This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...
- Hydrogel spheres compose a microporous structure for localized mRNA deliveryon February 29, 2024 at 1:52 pm
In a significant leap forward in the realm of regenerative medicine, a team at the Terasaki Institute for Biomedical Innovation has introduced a pioneering approach to mRNA therapy using microspheres ...
- 3D Systems: Another Difficult Year Aheadon February 28, 2024 at 8:54 pm
D Systems is implementing cost-cutting initiatives and focusing on regenerative medicine to stem losses and drive growth. Learn why DDD stock is a Hold.
- Pelage secures funds to develop regenerative medicine for hair losson February 28, 2024 at 4:49 am
Pelage Pharmaceuticals has secured $16.75m in a Series A financing round to further the development of PP405, a promising regenerative treatment for hair loss caused by androgenetic alopecia. GV led ...
- Contour Medical's an all-encompassing approach to regenerative medicine and functional wellnesson February 27, 2024 at 9:11 am
((SL Advertiser)) Contour Medical's an all-encompassing approach to regenerative medicine and functional wellness. To learn more, go to ContourMedical.com ...
- Albert Einstein College of Medicine to offer free tuition after billion-dollar gifton February 26, 2024 at 10:53 am
Students at the Albert Einstein College of Medicine in New York will receive free tuition after a $1 billion dollar donation from a former faculty member.
- QC Kinetix Launches Groundbreaking Clinical Trial to Enhance Musculoskeletal Pain Treatment Using Regenerative Medicineon February 22, 2024 at 6:45 am
CHARLOTTE, NC / ACCESSWIRE / February 22, 2024 / QC Kinetix, a leader in the field of regenerative medicine, announces the launch of a new ...
- Regenerative Medicine Market Size, Share, Industry Analysis, Trends, Forecast 2024-2032on February 21, 2024 at 6:14 pm
(MENAFN- IMARC Group) According to the latest report by IMARC Group, titled“ Regenerative Medicine Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032 ”, offers a ...
- Regenerative Medicine: A Ray Of Hope For Couples With Recurrent Implantation Failureon February 8, 2024 at 4:21 pm
According to Dr Mahajan, regenerative medicine can be a boon for couples with RIF, through which they can aspire their dream of parenthood. When asked about regenerative medicine, Dr Mahajan said ...
via Bing News